Insurance companies are more frequently refusing to cover the cost of prescription drugs, even when their plans promise that they will. This leaves patients less healthy and pharmaceutical companies stripped of incentive to innovate. American Society for Preventive Cardiology President Dr. Seth Baum explains why this problem is getting a lot worse, why it could stifle the advancement of new medicines and how individual patients can be a vital part of the solution.
